151 related articles for article (PubMed ID: 11244079)
21. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
[TBL] [Abstract][Full Text] [Related]
22. NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations.
Sun L; Sreedharan S; Plummer K; Fisher LM
Antimicrob Agents Chemother; 1996 Jul; 40(7):1665-9. PubMed ID: 8807059
[TBL] [Abstract][Full Text] [Related]
23. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.
Price CT; Kaatz GW; Gustafson JE
Int J Antimicrob Agents; 2002 Sep; 20(3):206-13. PubMed ID: 12385700
[TBL] [Abstract][Full Text] [Related]
24. A novel type I toxin-antitoxin system modulates persister cell formation in Staphylococcus aureus.
Habib G; Zhu J; Sun B
Int J Med Microbiol; 2020 Feb; 310(2):151400. PubMed ID: 32001143
[TBL] [Abstract][Full Text] [Related]
25. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P
J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936
[TBL] [Abstract][Full Text] [Related]
26. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
Roy SK; Kumari N; Pahwa S; Agrahari UC; Bhutani KK; Jachak SM; Nandanwar H
Fitoterapia; 2013 Oct; 90():140-50. PubMed ID: 23892000
[TBL] [Abstract][Full Text] [Related]
27. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
28. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
Fontaine F; Héquet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
Eur J Med Chem; 2015 May; 95():185-98. PubMed ID: 25817769
[TBL] [Abstract][Full Text] [Related]
29. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus.
Truong-Bolduc QC; Dunman PM; Strahilevitz J; Projan SJ; Hooper DC
J Bacteriol; 2005 Apr; 187(7):2395-405. PubMed ID: 15774883
[TBL] [Abstract][Full Text] [Related]
30. The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.
Truong-Bolduc QC; Hooper DC
J Bacteriol; 2007 Apr; 189(8):2996-3005. PubMed ID: 17277059
[TBL] [Abstract][Full Text] [Related]
31. Allele-based analysis revealed the critical functions of region 277-297 in the NorA efflux pump of Staphylococcus aureus.
Shang Y; Lv P; Li S; Wang W; Liu Y; Yang C
J Antimicrob Chemother; 2021 May; 76(6):1420-1427. PubMed ID: 33677568
[TBL] [Abstract][Full Text] [Related]
32. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
33. Structural and sequence requirements for the antisense RNA regulating replication of staphylococcal multiresistance plasmid pSK41.
Kwong SM; Firth N
Plasmid; 2015 Mar; 78():17-25. PubMed ID: 25634580
[TBL] [Abstract][Full Text] [Related]
34. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
[TBL] [Abstract][Full Text] [Related]
35. Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus.
Marchi E; Furi L; Arioli S; Morrissey I; Di Lorenzo V; Mora D; Giovannetti L; Oggioni MR; Viti C
Microbiol Res; 2015 Jan; 170():184-94. PubMed ID: 25081379
[TBL] [Abstract][Full Text] [Related]
36. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
Neyfakh AA; Borsch CM; Kaatz GW
Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010
[TBL] [Abstract][Full Text] [Related]
37. Evolutionary conservative analysis revealed novel functional sites in the efflux pump NorA of Staphylococcus aureus.
Shang Y; Lv P; Su D; Li Y; Liang Y; Ma C; Yang C
J Antimicrob Chemother; 2022 Feb; 77(3):675-681. PubMed ID: 34910133
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Fournier Dit Chabert J; Marquez B; Neville L; Joucla L; Broussous S; Bouhours P; David E; Pellet-Rostaing S; Marquet B; Moreau N; Lemaire M
Bioorg Med Chem; 2007 Jul; 15(13):4482-97. PubMed ID: 17498961
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Brincat JP; Carosati E; Sabatini S; Manfroni G; Fravolini A; Raygada JL; Patel D; Kaatz GW; Cruciani G
J Med Chem; 2011 Jan; 54(1):354-65. PubMed ID: 21141825
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.
Mesak LR; Davies J
Res Microbiol; 2009 Dec; 160(10):785-91. PubMed ID: 19818400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
